Project Grant AID612G001000001

This $169,035 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support research to model the impact of interventions to reduce transmission of typhoid-causing Salmonella bacteria in the Indo-Pacific region. The key products and services to be delivered include: 1) using novel serosurveillance techniques to estimate the incidence of typhoid fever, 2) leveraging genomic methods...

This federal Project Grant award of $709,872 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to develop and test a couple-based intervention to address perinatal depression and improve prevention of mother-to-child transmission (PMTCT) of HIV adherence in Malawi. The project has two main objectives: (1) to develop a couple-based intervention using problem-solving therapy and couple...

This Project Grant award from the National Institutes of Health's Fogarty International Center (CFDA 93.989 - International Research and Research Training) will provide $559,341 over 5 years to a collaborative research partnership between Henry Ford Health and Michigan State University Health Sciences. The award will support two key research objectives: A prospective cohort study to evaluate the accuracy of novel, non-invasive tuberculosis (TB) diagnostic strategies utilizing stool and urine...

The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $1,303,086 Project Grant (R01AI181383) to the University of Maryland, Baltimore to conduct a longitudinal cohort study on the epidemiological impact of malaria prevention interventions on school-age children in Ghana. The study aims to understand the effects of Seasonal Malaria Chemoprevention (SMC) and the RTS,S malaria vaccine on the burden of...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to demonstrate the feasibility, acceptability, and preliminary effectiveness of a Focal Mass Drug Administration (FMDA) program for household members of pregnant women to protect against Malaria in Pregnancy (MIP). The $335,559 award will fund a pilot randomized controlled trial in rural Western Uganda to: 1)...

This federal Project Grant award, valued at $1,553,810.00 and granted by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), is funding research to develop a genomic surveillance approach for monitoring the emergence of artemisinin resistance in Plasmodium falciparum malaria parasites in Africa. The primary objectives are to: 1) Identify parasite genetic loci under selection over time following implementation...

This $108,916 Project Grant awarded by the National Institutes of Health Fogarty International Center (CFDA 93.989 - International Research and Research Training) will allow Dr. Clifford George Banda to characterize the pharmacokinetic and safety profiles of the antimalarial drugs lumefantrine and amodiaquine in two key target populations: African children with severe acute malnutrition and adults living with HIV on dolutegravir-based antiretroviral therapy. The study aims to inform the...

This federal Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), is focused on developing targeted antibiotic therapy strategies for Shigella infections among children in low-resource settings. The $746,813 award will support a multi-year study to characterize the impact of Shigella on diarrhea outcomes, evaluate the use of fecal biomarkers to identify Shigella cases, and...

This $8,536,000 Cooperative Agreement award from the Centers for Disease Control and Prevention's (CDC) Investigations and Technical Assistance program (CFDA 93.283) aims to REINFORCE IMMUNIZATION SYSTEMS FOR CONSEQUENTIAL GEOGRAPHIES(RISE4CGS) in the Democratic Republic of Congo, Ethiopia, and Nigeria. The award recipient, African Field Epidemiology Network LTD (AFENET), is a non-profit organization based in Uganda that specializes in public health initiatives across sub-Saharan Africa. Over...

This $690,500 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate the determinants of poor responsiveness to the booster dose of the RTS,S malaria vaccine in African children. The primary research will be conducted by Trustees of Boston University, with a sub-award to Kamuzu University of Health Sciences in Malawi to recruit participants and...